The Chinese are clearly trying to reverse engineer DCVax.
Why? It works!
Here's a 2023 paper with a dendritic vaccine (PERCELLVAC), PolyICLC, and BMY's Opdivo.
The paper was compassionate use data based off a previous Phase I trial. We are much farther along but this goes to show that the world are watching Northwest Biotherapeutics, UCLA, and Linda Liau.